Rafael Palmeiro’s positive drug test may forever doom his Hall of Fame case, but to the extent that those who would vote against him do so by virtue of his finger-wagging performance in front of Congress, this may be of interest:
The former head of the Congressional subcommittee that Mark McGwire, Sammy Sosa and Jose Canseco testified in front of told FanHouse that Palmeiro indeed may not have knowingly used steroids despite a positive test days after he recorded his 3,000th hit—a benchmark that typically ensures entry to the Hall of Fame. Palmeiro will find out Wednesday if he’ll be a first-ballot selection as the Baseball Writers’ Association of America reveals if anybody reached the 75% threshold for induction.
“I feel bad for him,” said Tom Davis, a retired Virginia Congressman who now is director of Federal Government Affairs for Deloitte & Touche. “I believe that he didn’t know he was taking steroids. I think he told the truth. We conducted an investigation and that was the conclusion our investigators came to.”
My guess — and it’s only a guess — is that Palmeiro was more negligent than he was duplicitous. I think he was part of a culture in which guys were simply not all that critical about supplements, shots and whatever else they were using, to the extent that many of them didn’t know and didn’t really care all that much about the specifics. “Here, Raffy: take this. It’s B-12.” Sure, he thought, because he never thought all that much about it at all. He wasn’t locked in a bathroom stall twirling his mustache and chortling about how he had pulled one over on Congress.
Not that this exonerates him in the slightest. In the post-testing era every player has an obligation to know what it is they’re taking, and one can’t be let off the hook simply because they were willfully ignorant or deluded about what went into their bodies. I’ve never seen a single suggestion that Palmeiro’s test was a false-positive. Absent anything like that, it’s implausible to say that he wasn’t using a banned substance.
But it may impact our characterization of the guy. He’s made out to be evil by so many. In large part because of that image of him wagging his finger. True evil is rare, however, and I’m pretty doubtful Palmeiro fits that description. He was just uncurious and careless. In my mind, that’s a venial sin, not a mortal one.
The Associated Press is reporting that the Cubs and starter Jake Arrieta have avoided arbitration, agreeing to a $10.7 million salary for the 2016 season. That marks the highest salary on a one-year deal for a pitcher with four years of service, the AP notes. Arrieta and the Cubs were set to go before an independent arbitrator but now can simply focus on the season ahead.
Arrieta, 29, is in his second of three years of arbitration eligibility. He had filed for $13 million while the Cubs countered at $7.5 million. The $5.5 million gap was the largest among players who did not come to terms with their respective teams by the January deadline. The $10.7 million salary is $450,000 above the midpoint between the two submitted figures.
Arrieta won the National League Cy Young Award for his performance this past season, narrowly edging out Zack Greinke, then with the Dodgers. Arrieta led the majors with 22 wins, four complete games, and three shutouts. With that, he compiled a 1.77 ERA and a 236/48 K/BB ratio across 229 innings.
Once a top prospect in the Orioles’ minor league system, Arrieta struggled in the majors but found immediate success with the Cubs in 2013 after the O’s traded him along with Pedro Strop in exchange for Steve Clevenger and Scott Feldman.
Per Baseball America’s Matt Eddy, the Giants have signed infielder Conor Gillaspie to a minor league deal. Gillaspie was selected by the Giants in the supplemental round of the 2008 draft, then was traded to the White Sox in February 2013.
Gillaspie, 28, hit a meager .228/.269/.359 with four home runs and 24 RBI in 253 plate appearances between the White Sox and Angels during the 2015 season. Almost all of his playing time has come at third base but he can also play first base if needed.
The Giants, thin on depth, will allow Gillaspie to audition in spring training for a spot on the 25-man roster.
Jon Morosi of FOX Sports reports that free agent reliever Joe Nathan, recovering from Tommy John surgery, plans to pitch in 2016 according to his agent Dave Pepe. According to Pepe, Nathan’s workouts are “going well” and the right-hander is “definitely planning on playing this year.”
Nathan, 41, got the final out on Opening Day (April 6) against the Twins before going on the disabled list with a flexor strain in his right elbow, causing him to miss the next 161 games. He will likely be able to contribute out of the bullpen in late May or early June if he has no setbacks. On a minor league deal or incentive-laden major league deal, Nathan could make for a low-risk gamble.
Over a 15-season career that dates back to 1999 (he did not pitch in the majors in 2001 or 2010), Nathan has 377 saves with a 2.89 ERA and a 967/340 K/BB ratio over 917 innings.
On Thursday, we learned that the Diamondbacks were still considering free agent reliever Tyler Clippard. You can add the Rays to the list as well, per Marc Topkin of the Tampa Bay Times.
The Rays traded lefty reliever Jake McGee to the Rockies in exchange for outfielder Corey Dickerson in late January, so Clippard would be able to slot right in behind closer Brad Boxberger. Clippard, 30, compiled a 2.92 ERA with 64 strikeouts and 31 walks over 71 innings in a season split between the Athletics and Mets. The strikeout rate was at its lowest since the right-hander become a full-time reliever in 2009, and his walk rate was at its highest since 2010, which may be a factor in his still being a free agent in February.